In 1946, Dr. Henry Jordan, a surgeon and medical trustee of NHF, began a program for the orthopedic treatment of hemophilia patients. The study was funded and conducted in cooperation with NHF, and was run out of Lenox Hill Hospital in New York City. The study included 110 patients and ran through 1956.

Dr. Henry Jordan, a trustee of the medical advisory council of the National Hemophilia Foundation, publishes a well-received book on treatments for hemophilic arthropathy (joint damage). The research cases featured in the book were funded by NHF.

Lee, the son of NHF's founders, was born in 1941* but was not diagnosed with hemophilia until he experienced an abdominal bleed 14 months later. *NOTE: Some public records indicate Lee's birth year as "about 1942" despite NHF's official record memos having his birth year listed as 1941.

Dr. Henry H. Jordan, an orthopedic surgeon who was a pioneer in the orthopedic treatment of hemophiliacs passed his way. Throughout his career, much of his work was funded by NHF.

The first-ever recipients of the Jeanne Marie Lusher Fellowship are announced.

In a blog post, NIH Director Dr. Francis Collins says that "Gene therapy represents a possible cure for hemophilia A."

The Hemophilia SNF Access Act becomes law, thanks to the voices and concerns of NHF and HFA advocates.

NHF becomes an endorsing partner of the first-ever Telehealth Awareness Week.

NHF hosts virtual State of the Science Research Summit to help shape the National Research Blueprint